MEDTRONIC VASCULAR GALWAY UNLIMITED COMPANY

Location

Founded

1989-12-19

Risk Signals

4960 news mentions monitored

Industry Context

This company is tracked across risk categories, including those related to its sector (e.g., Surgical and Medical Instruments and Apparatus, Drugs, Drug Proprietaries, and Druggists' Sundries), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.

Recent Articles about MEDTRONIC VASCULAR GALWAY UNLIMITED COMPANY

Live alerts from global media, monitored by Business Radar

Cosmo share still falls deep into the minus: growth thanks to key products in 2024 | 06.03.25 |

2025-03-06 (finanzen.ch)

Cosmo share still falls deep into the minus: growth thanks to key products in 2024 | 06.03.25 |

The specialty pharmaceutical company Cosmo recorded a leap in profits in 2024.

Read more
US quarterly: it is the day of analog devices and Carvana |

2025-02-19 (investire.biz)

US quarterly: it is the day of analog devices and Carvana |

Let's see how the US quarterly of yesterday and the expectations for the companies that will publish the results have gone

Read more
Company results this week: Kofola, Photon Energy, Walmart, Alibaba, .. | .cz

2025-02-18 (fxstreet.cz)

Company results this week: Kofola, Photon Energy, Walmart, Alibaba, .. | .cz

The result season continues. In the Czech Republic on Monday, Kofola's management will announce its results and Photon Energy energy company on Wednesday. In Germany from the DAX Index this week, the German car manufacturer Mercedes-Benz and aircraft manufacturer and air technology Airbus will be reported. In the UK, for example, Rio Tinto and HSBC are announced. In the US this week, 44 companies from the S&P 500 index will be reported. The retail chain of Walmart and Medtronic healthcare facilities will be published. In China, the technology giant Alibaba and the largest BAIDA internet search engine announce its economic results.

Read more
Pipeline Embolization Device for intracranial aneurysms presenting with mass effect: a large Chinese cohort

2024-10-24 (bmj.com)

Pipeline Embolization Device for intracranial aneurysms presenting with mass effect: a large Chinese cohort

Background Unruptured intracranial aneurysm treatment aims to reduce the risk of aneurysm rupture and bleeding, relieves symptoms and improve the quality of life for patients. This study aimed to assess the safety and efficacy of Pipeline Embolization Device( PED, Covidien/Medtronic, Irvine, CA)

Read more
SHAM-PVI Study: Pulmonary Vein Isolation Versus Sham Intervention in Symptomatic AF

2024-10-07 (secardiologia.es)

SHAM-PVI Study: Pulmonary Vein Isolation Versus Sham Intervention in Symptomatic AF

This study evaluates whether the benefit of pulmonary vein ablation in the treatment of atrial fibrillation is due to a placebo effect.

Read more
Pulmonary Vein Isolation vs Sham Intervention in Symptomatic Atrial Fibrillation

2024-09-02 (jamanetwork.com)

Pulmonary Vein Isolation vs Sham Intervention in Symptomatic Atrial Fibrillation

This randomized clinical trial assesses the effect of pulmonary vein isolation vs a sham procedure on atrial fibrillation burden at 6 months in patients

Read more
Medtronic recalls endotracheal tube products

2024-07-19 (medicaldevice-network.com)

Medtronic recalls endotracheal tube products

Medtronic still dominates the endotracheal tube market, but the incident is expected to have a noticeable effect on future sales.

Read more
Medtronic Executive Retirement Signals Leadership Change

2024-06-05 (tipranks.com)

Medtronic Executive Retirement Signals Leadership Change

The latest update is out from Medtronic (MDT). Rob ten Hoedt, a high-ranking executive at Medtronic plc, has announced his retirement, set to take effect on June 28...

Read more
Sustainability: a life sciences perspective

2024-05-05 (scientistlive.com)

Sustainability: a life sciences perspective

Driving sustainability in life sciences industry through digital technologies

Read more
TCT 2024: Two-year SPYRAL HTN-ON MED show “consistent” effect of renal denervation

2024-02-29 (cardiovascularnews.com)

TCT 2024: Two-year SPYRAL HTN-ON MED show “consistent” effect of renal denervation

Medtronic has announced new, long-term data from the SPYRAL HTN-ON MED clinical trial that showed subjects who underwent radiofrequency renal denervation with the Symplicity Spyral renal denervation system had significantly greater reductions in 24-hr ambulatory systolic blood pressure, and

Read more
Medtronic names Raman Venkatesh as first chief sustainability officer

2024-02-16 (yahoo.com)

Medtronic names Raman Venkatesh as first chief sustainability officer

Venkatesh will be responsible for leading the development and execution of Medtronic’s environmental sustainability strategy.

Read more
Medtronic Doubles Down on Sustainability Efforts

2024-02-14 (mddionline.com)

Medtronic Doubles Down on Sustainability Efforts

The Dublin-based company has tapped Raman Venkatesh to be its first VP & Chief Sustainability Officer.

Read more

Never miss a headline about MEDTRONIC VASCULAR GALWAY UNLIMITED COMPANY

Set up smart alerts with Business Radar and receive real-time updates on any new risk signal or major news story.

  • ✔️ Used by 100+ compliance teams and analysts
  • ✔️ Covers 154M+ sources in 40+ languages